Inga Back, MPH

MPH

All articles by Inga Back, MPH

Sleep Disturbances Are More Common in Psoriatic Arthritis vs Psoriasis

Inga Back, MPH

April 28, 2022

Researchers sought to determine the prevalence of sleep disturbances among patients with psoriatic arthritis vs those with psoriasis and healthy individuals.

Neuromuscular Disorders

Incidence, Prevalence, and Mortality of Dermatomyositis in Adults Determined

Inga Back, MPH

December 2, 2021

Using the ACR/EULAR criteria, researchers studied the population-based incidence, prevalence, and mortality of dermatomyositis in adults.

Stroke

AHA Presidential Statement: Link Between Opioid Use, Cardiovascular Disease, and Stroke

Inga Back, MPH

September 8, 2021

The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.

Seizures and epilepsy (≥2 unprovoked seizures) are more common in patients with APS compared with the general population.6,10 Between 3% and 10% of patients with APS have seizures/epilepsy, a prevalence that is 10 times greater than that of the general population.10 In half of these patients, epilepsy onset is after diagnosis.3 Epilepsy is more common in APS secondary to SLE vs primary APS (13.7% vs 6%; P <.05).11 Evidence of a correlation between aPL positivity and seizure is inconclusive.10 Seizures and epilepsy in patients with APS are primarily attributable to vascular disease.6 In a cohort study of 538 patients with APS, the odds ratio for epilepsy was 4.05 (95% CI, 2.05-8.00) in those with a prior central nervous system thromboembolic event.11 Epilepsy was also associated with higher rates of thrombocytopenia, livedo reticularis, and autoimmune hemolytic anemia.11 Some patients with APS with epilepsy have normal brain MRI results,3 and in vitro studies have implicated interactions between autoantibodies and neural structures.6

Neurocognitive Disorders

Consensus Needed to Address Inconsistency in Metrics and Definitions Used to Assess Cognitive Impairment in SLE

Inga Back, MPH

July 21, 2021

Researchers highlighted the importance of a consensus to address inconsistencies in the metrics and definitions used for cognitive impairment assessment in systemic lupus erythematosus.

Next post in Neurocognitive Disorders

Inga Back, MPH

All articles by Inga Back, MPH

Sleep Disturbances Are More Common in Psoriatic Arthritis vs Psoriasis

Incidence, Prevalence, and Mortality of Dermatomyositis in Adults Determined

AHA Presidential Statement: Link Between Opioid Use, Cardiovascular Disease, and Stroke

Consensus Needed to Address Inconsistency in Metrics and Definitions Used to Assess Cognitive Impairment in SLE

Reading Problems in Childhood Tied to Poorer Memory Scores in Adulthood